Bottom line
Is GPROX a good fund? The bottom line
GPROX is the Investor Class share class of Grandeur Peak Global Reach Fund, an actively managed international stock mutual fund from Grandeur Peak Global.
Its expense ratio is 1.5% — about $150 a year on every $10,000 invested, more expensive than 88% of international stock funds we track.
It returned +8.8% over one year, −0.6% a year over five years, +7.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $80.9 million in net assets and 189 holdings, its largest position is Lemaitre Vascular Inc (1.4%) and the top 10 make up 11.9% of the portfolio.
What to watch
- Expensive for its category (1.5%)
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What GPROX invests in
The Funds investment objective is long-term growth of capital.
Strategic Focus The Fund invests primarily in foreign and domestic small- and micro-cap companies. Under normal market conditions, the Adviser invests the Funds assets primarily in equity securities (including common stock, preferred stock, and securities convertible into common stock) of foreign and domestic companies with market capitalizations of less than $5 billion at the time of purchase. The Fund typically invests in securities issued by companies economically tied to at least ten countries, including the United States. The Fund invests a significant portion of its total assets (at least 40% under normal market conditions) at the time of purchase in securities issued by companies that are economically tied to countries outside the United States. The Adviser considers a company to be economically tied to a country if at least one of the following attributes exists: the company…
From the fund's prospectus (filed Aug 28, 2026).
GPROX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GPROX | +8.8% | −0.6% | +7.7% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What GPROX costs
On a $10,000 investment, GPROX's 1.5% expense ratio costs about $150 a year. The prospectus estimates $2,011 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
GPROX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Lemaitre Vascular Inc | 1.39% |
| 2 | Virbac Sa | 1.32% |
| 3 | Dexcom Inc | 1.24% |
| 4 | Ollie's Bargain Outlet Holdings Inc | 1.17% |
| 5 | Qualitas Ltd | 1.17% |
| 6 | Marex Group Ltd | 1.15% |
| 7 | Vimian Group Ab | 1.14% |
| 8 | Pinnacle Investment Management Group Ltd | 1.13% |
| 9 | S.j.s. Enterprises Ltd | 1.08% |
| 10 | Asker Healthcare Group Ab | 1.06% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 11.9% of the fund. See all top 25 holdings and asset mix →